The FDA has started exploring how AI can be used to accelerate drug approvals in collaboration with OpenAI amid oversight ...

The AI moved the cake (which had been barely visible behind the paper towel roll in the original still) to be the focal point ...

OpenAI has reportedly met with officials from the U.S. Food and Drug Administration (FDA) to discuss the use of artificial ...

Google's antitrust trial, like Microsoft's, may have inadvertently spurred innovation by competitors, challenging its search ...

Today, we’re all making strides forward at the same time. This presents an opportunity not just for us, but for everyone.

SoftBank Group Corp.’s plans to invest $100 billion in artificial intelligence infrastructure in the US have slowed, with ...